Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Stellantis
STLA
|
$292M |
| 2 |
Constellation Brands
STZ
|
$288M |
| 3 |
VMW
VMware, Inc
VMW
|
$273M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$261M |
| 5 |
NiSource
NI
|
$240M |
Top Sells
| 1 |
Microsoft
MSFT
|
$2.05B |
| 2 |
Apple
AAPL
|
$1.81B |
| 3 |
UnitedHealth
UNH
|
$1.01B |
| 4 |
Exxon Mobil
XOM
|
$862M |
| 5 |
Tesla
TSLA
|
$834M |
Sector Composition
| 1 | Technology | 27.58% |
| 2 | Consumer Discretionary | 11.38% |
| 3 | Healthcare | 10.81% |
| 4 | Financials | 10.71% |
| 5 | Communication Services | 6.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4451
PAVmed
PAVM
$10.6M
| – | – |
-8,000
| Closed | -$4K |
|
4452
Paymentus
PAY
$4.88B
| – | – |
-217
| Closed | -$2K |
|
4453
Invesco Aerospace & Defense ETF
PPA
$6.22B
| – | – |
-1,300
| Closed | -$102K |
|
4454
SPDR ICE Preferred Securities ETF
PSK
$812M
| – | – |
-30,179
| Closed | -$990K |
|
4455
Plus Therapeutics
PSTV
$45.3M
| $0 | ﹤0.01% |
1
| – | – |
|
4456
Pulmatrix
PULM
$18M
| $0 | ﹤0.01% |
5
| – | – |
|
|
QD
4457
Qudian
QD
$753M
| – | – |
-981,160
| Closed | -$935K |
|
4458
Quince Therapeutics
QNCX
$85.9M
| $0 | ﹤0.01% |
+100
| New | – |
|
4459
Radware
RDWR
$1.08B
| $0 | ﹤0.01% |
10
-15,768
| -100% | – |
|
4460
Dr. Reddy's Laboratories
RDY
$11.8B
| – | – |
-8,805
| Closed | -$456K |
|
|
RGLS
4461
DELISTED
Regulus Therapeutics
RGLS
| $0 | ﹤0.01% |
+5
| New | – |
|
4462
SAB Biotherapeutics
SABS
$19.3M
| $0 | ﹤0.01% |
+54
| New | – |
|